Search
Sophia Genetics SA
SOPHAdd to Watchlist
5.350USD
-0.240-4.29%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
384.08MMarket Cap
LossP/E TTM
More Details of Sophia Genetics SA Company
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.
Sophia Genetics SA Info
Ticker SymbolSOPH
Company nameSOPHiA GENETICS SA
IPO dateJul 23, 2021
CEOCamblong (Jurgi)
Number of employees423
Security typeOrdinary Share
Fiscal year-endJul 23
AddressLa Piece 12
CityROLLE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountrySwitzerland
Postal codeCH-1180
Phone41216941060
Websitehttps://www.sophiagenetics.com/
Ticker SymbolSOPH
IPO dateJul 23, 2021
CEOCamblong (Jurgi)
Company Executives of Sophia Genetics SA
Name
Name/Position
Position
Shareholding
Change
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
2.98M
-0.94%
Mr. Ross J Muken
Mr. Ross J Muken
President
President
625.61K
-0.07%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
509.18K
-0.79%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Mr. Troy M. Cox
Mr. Troy M. Cox
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
294.96K
+6.69%
Mr. George A. Cardoza
Mr. George A. Cardoza
Chief Financial Officer
Chief Financial Officer
217.28K
+8.85%
Mr. Didier Hirsch
Mr. Didier Hirsch
Non-Executive Independent Director
Non-Executive Independent Director
204.44K
+9.65%
Dr. Philippe Menu, M.D., Ph.D.
Dr. Philippe Menu, M.D., Ph.D.
Chief Medical Officer and Chief Product Officer
Chief Medical Officer and Chief Product Officer
128.68K
-7.77%
Mr. Daan Van Well
Mr. Daan Van Well
Chief Legal and Compliance Officer
Chief Legal and Compliance Officer
--
--
Ms. Manuela Da Silva Valente
Ms. Manuela Da Silva Valente
Chief People Officer
Chief People Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
2.98M
-0.94%
Mr. Ross J Muken
Mr. Ross J Muken
President
President
625.61K
-0.07%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
509.18K
-0.79%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Mr. Troy M. Cox
Mr. Troy M. Cox
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
294.96K
+6.69%
Mr. George A. Cardoza
Mr. George A. Cardoza
Chief Financial Officer
Chief Financial Officer
217.28K
+8.85%
FAQs
Who are the top five shareholders of Sophia Genetics SA?
The top five shareholders of Sophia Genetics SA are: Dr. Jurgi Camblong, Ph.D.
How many institutions hold shares of Sophia Genetics SA (SOPH)?
As of 2026Q1, 89 institutions hold shares of Sophia Genetics SA, with a combined market value of approximately 27.73M, accounting for 38.63% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -11894064.00.